NVO•benzinga•
Novo Nordisk Spokesperson Said Cagrisema Trial Permitted Dose Reductions; Statistically Significant Results Were Achieved Even Though Only 57% Of Patients On Cagrisema Reached The Highest Dose
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 20, 2024 by benzinga